Leon H Kircik M.D.
Transcription
Leon H Kircik M.D.
Leon H Kircik M.D. Clinical Associate Professor of Dermatology Indiana University School of Medicine Mount Sinai Medical Center Physicians Skin Care, PLLC Louisville, KY © 2008 SkinMedica, Inc. All rights reserved. I have received funding either as an investigator, consultant, or a speaker from the following pharmaceutical companies: • • • • • • • • • • • • • • • • • • • • • • • Abbott Acambis Allergan Amgen Astellas Asubio Berlex Biogen-Idec Biolife Breckenridge Pharma Centocor Colbar Collagenex Combinatrix Connetics Coria Dermik Dow Dusa Pharmacueticals Ferndale Galderma Genentech Glaxo-Smith Kline • • • • • • • • • • • • • • • • • • • • • • • • HealthPoint Intendis Innovail Johnson & Johnson 3M Leo Medicis NanoBio Novartis Nucryst Obagi OrthoNeutrogena Pfizer PharmaDerm QLT Quatrix Serono SkinMedica Stiefel TolerRx Triax Pharmaceuticals UCB Valeant Warner & Chilcott PAGE 2 © 2008 SkinMedica, Inc. All rights reserved. Functions of Human Skin that Decline with Age • • • • Cell replacement Injury response Barrier function Chemical clearance • Sensory perception • Mechanical protection © 2008 SkinMedica, Inc. All rights reserved. • Immune responsiveness • Vascular responsiveness • Thermoregulation • Sweat production • Sebum production • Vitamin D production PAGE 3 1 Clinical Differences in Chronological Aging & UV-Induced Premature Aging UV-Induced Premature Aging Chronological Aging • Thin, dry, pale, delicate skin • Fine wrinkles • Fat atrophy • • • • • • • • • Dry, rough, dull, yellowish skin Deep lines and wrinkles Elastosis, laxity Dyspigmentation (eg mottled hyperpigmentation, lentigines, irregular depigmentation) Enlarged pores Telangiectasia Actinic keratoses Skin cancers PAGE 4 © 2008 SkinMedica, Inc. All rights reserved. UV Induces Loss of Collagen UV exposure ↓ Reactive oxygen species (H202, OH•) ↓ ↑ AP-1 induction ↑ collagenase ↑ gelatinase B ↓ procollagen I gene expression ↓ collagen Fisher et al., 2000. PAGE 5 © 2008 SkinMedica, Inc. All rights reserved. Collagen Loss and Repair Leads to Wrinkles • Following UV exposure, collagen is cleaved and degraded by enzymes • Fragments can inhibit collagen formation and contribute to misrepair • Repeated collagen repair results in – Disorganized collagen matrix (imperfect repair of collagen fragments → subclinical microscars) – Permanent reduction in collagen – Wrinkles Sun Damage Fisher et al., 1997. © 2008 SkinMedica, Inc. All rights reserved. PAGE 6 2 The Spectrum of Skin Damage Due to Sun Exposure Roughness Sunburn Fine Actinic Wrinkling Keratosis Mottled Deep Carcinoma Hyperpigmentation Wrinkling From: Focus on Photodamage: A Medical Problem. Parsipanny, NJ: Skin Phototrauma Foundation: 1990:2-28. PAGE 7 © 2008 SkinMedica, Inc. All rights reserved. Histology of Sun-Damaged Skin • • • • Loss of collagen I, III, VII, and fibrillin → Wrinkling ↑ size and activity of melanocytes → Hyperpigmentation Overall ↑ density of melanocytes Irregular distribution of melanosomes within epidermal keratinocytes • Localized absence of melanocytes → Depigmentation → Irregular/mottled dyspigmentation • Cytologic atypia • Disorderly maturation of keratinocytes → Actinic keratoses © 2008 SkinMedica, Inc. All rights reserved. PAGE 8 Solar Elastosis • Elastin is major component in solar elastosis but also contains elastin associated microfibrils, fibrillin, fibronectin, GAG, etc. but no normal elastic fibers with typical morphology. • Therefore, these elastic structures are not functional in providing elasticity and resiliency to the skin. © 2008 SkinMedica, Inc. All rights reserved. PAGE 9 3 • Medical – Non-Invasive – Economic – Minimal Side Effects – ↓ Recovery Period • Surgical – Invasive – Cost – ↑ Recovery Period – ↑ Side Effects – ↑ Anesthesia PAGE 10 © 2008 SkinMedica, Inc. All rights reserved. Noninvasive Management of the Aging Face • Regenerate – Creams, Chemical peels, microdermabrasion, nonablative “resurfacing” • Relax – Botox • Replace – Multiple injectable dermal fillers PAGE 11 © 2008 SkinMedica, Inc. All rights reserved. What Are Growth Factors & Cytokines? • Naturally occurring proteins capable of stimulating – Cellular Growth, Proliferation and Differentiation • Produced by all cell types including skin cells – Fibroblasts, Keratinocytes, Lymphocytes, Mast cells • Generally act in close proximity of their production • Cytokines are associated with immune system cells and play a key role in modulation of inflammation Two TGF-β3 molecules (red and blue) binding to two receptors each (green and yellow) to form an active complex. Image courtesy of University of Texas Health Science Center at San Antonio © 2008 SkinMedica, Inc. All rights reserved. PAGE 12 4 Role of Growth Factors in Inflammation and Skin Remodeling • Inflammation leads to generation of ROS and enzymes that degrade ECM and secrete GFs • GFs induce dermal fibroblasts to initiate ECM production and skin repair • GFs further induce dermal fibroblasts to produce extended dermal remodeling ROS - Reactive Oxygen Species ECM - Extracellular Matrix PAGE 13 © 2008 SkinMedica, Inc. All rights reserved. Skin Aging • Over time, the body loses the ability to complete the healing process, resulting in: – Up to 20% reduction in collagen1 – Excessive type 3 collagen – Loss of stored antioxidants – Loss of skin elasticity – Wrinkle & fine line formation References: 1. Schwartz E et al. Photochem Photobiol 1993;53:841-844. PAGE 14 © 2008 SkinMedica, Inc. All rights reserved. Role of Growth Factors in Reversal of Aging • GF active during skin remodeling following are crucial for the reversal of aging • Through normal aging, production and level of growth factors decrease 1,2 Extrinsic Aging Intrinsic Aging • Replenishing growth factors in skin can induce remodeling and reversal of aging References: 1. Mori Y et al., Arch. Dermatol Res 1998;290:158-162 2. Canalis E., J Clin Endocrinol Metabol 1994;78:1009-1010. © 2008 SkinMedica, Inc. All rights reserved. PAGE 15 5 Can Topical GF Produce Response in Dermis? • GF penetrate into superficial epidermis and initiate a communication cascade1 • Topical growth factors bind to receptors on epidermal keratinocytes2 • Keratinocytes secrete endogenous growth factors that can stimulate dermal fibroblasts1-3 References: 1: Ansel J, et al., J Invest Dermatol. 1990;94:101S-107S. 2: Werner S, et al. J Invest Dermatol. 2007;127:998-1008. 3: Babu M, Wells A, Wounds, 2001;13:183-189. PAGE 16 © 2008 SkinMedica, Inc. All rights reserved. Physiologically Balanced Growth Factors • GF are part of a complex cellular communication network and work in harmony with each other • Combinations similar to those in physiological environment must be maintained to provide optimal benefits • Like breast milk, ideal GF combination cannot be synthetically made Schematic reprinted from: Werner S, et al. J Invest Dermatol;127:998-1008; 2007 PAGE 17 © 2008 SkinMedica, Inc. All rights reserved. Effects of Aging on Growth Factors • Through normal aging, production and level of growth factors decrease1,2 • Growth factor levels peak in youth when our bodies fully develop 1. Mori Y et al., Arch. Dermatol Res 1998;290(3):158-162 2. Canalis E., J Clin Endocrinol Metabol 1994;78(5):1009-1010. © 2008 SkinMedica, Inc. All rights reserved. Copyright ©2007 SkinMedica, Inc. All rights reserved. Copyright ©2008 SkinMedica, Inc. All rights reserved. 18 PAGE 18 6 How Topical Growth Factors Penetrate Large molecules can penetrate into the skin • Through hair follicles and sweat glands1,2,3 • Through impaired skin barrier4,7 • As particles in the size range of 10 -100nm5 • With penetration enhancers alter the lipid barrier6 1. Lademann J et al. Skin Pharmacol Physiol. 2006;19(4):232-236. 2. Yu WH et al., J Invest Dermatol. 1999 Mar;112(3):370-375. 3. Ciotti SN, Weiner N, J Liposome Res. 2002 Feb-May;12(1-2):143-148. 4. Jakasa I, et al., Exp Dermatol. 2006;15:801-807. 5. Baroli B, et al., J. Invest Derm 2007; 127: 1701–1712. 6. Cui CY, et al. Biol Pharm Bull 2005;28:2279-2288. 7. Homey B, et al., Chem Immunol Allergy. 2007;93:181-194 © 2008 SkinMedica, Inc. All rights reserved. Copyright ©2008 SkinMedica, Inc. All rights reserved. PAGE 19 NouriCel-MD® A Unique Growth Factor Blend NouriCel-MD is the solution in which dermal fibroblasts grow in culture. It is rich in human growth factors, soluble collagen, antioxidants, and matrix proteins – FDA Approved Human Fibroblast Cell Banks – Patented Advanced Manufacturing Process – Active Source of Growth Factors – Stable Growth Factors – Proven Clinical Results Collection of Sterile NouriCel-MD PAGE 20 © 2008 SkinMedica, Inc. All rights reserved. Patented Manufacturing Process Growing Living Human Tissues Secreted Growth Factors Concentrated and Stabilized to Make NouriCel-MD © 2008 SkinMedica, Inc. All rights reserved. PAGE 21 7 TNS Recovery Complex® with NouriCel-MD® • Final Product: – 93.6% NouriCel-MD • NouriCel-MD Contains: – – – 110 growth factors and cytokines Antioxidants Matrix proteins • Aqueous Gel Formulation – – © 2008 SkinMedica, Inc. All rights reserved. Surfactant Free, Alcohol Free Oil Free, Non-Comedogenic Copyright ©2008 SkinMedica, Inc. All rights reserved. PAGE 22 Key Growth Factors • Vascular Endothelial Growth Factor VEGF – Chemotactic and mitogenic to endothelial cells and promotes angiogenesis – Believed to increase blood vessel permeability to improve tissue nutrition • Platelet Derived Growth Factor PDGF AA, PDGF BB – Chemotactic and mitogenic to fibroblasts – Believed to regulate cell growth and division in wound healing • Transforming Growth Factor TGFβ1, TGFβ2, TGFβ3 – Chemotactic and mitogenic to fibroblasts – Regulates matrix protein including collagen and proteoglycans • Tissue Inhibitor of Metalloproteinases TIMP1, TIMP2 – Regulates activity of enzymes preventing breakdown of collagen and hyaluronic acid © 2008 SkinMedica, Inc. All rights reserved. Copyright ©2008 SkinMedica, Inc. All rights reserved. PAGE 23 Supplemental Growth Factors • Fibroblast Growth Factors bFGF (FGF-2), FGF-4, FGF-6, KGF (FGF-7), FGF-9 – Believed to promote skin cell growth and tissue repair • Hepatocyte Growth Factor HGF – Believed to promote three dimensional tissue growth • Insulin Like Growth Factor IGF1, IGFBP1, IGFBP2, IGFBP3, IGFBP6 – Believed to promote cell growth and multiplication • Placenta Growth Factor PLGF – Believed to promote endothelial cell growth • Bone Morphogenetic Protein BMP7 – Believed to promote development of nerve cells in developing tissue • Interleukins (15 Different Interleukins including IL10 and IL13) – Believed to play a critical role in inflammation and wound healing • Colony Stimulating Factor GCSF, GM-CSF, M-CSF – Believed to induce secretion of other cytokines © 2008 SkinMedica, Inc. All rights reserved. Copyright ©2008 SkinMedica, Inc. All rights reserved. PAGE 24 8 TNS Recovery Complex®: Clinical Studies PAGE 25 Copyright ©2008 SkinMedica, Inc. All rights reserved. © 2008 SkinMedica, Inc. All rights reserved. Study Design • 1:1 Randomized, vehicle-controlled, double-blind study • Protocol: Cetaphil Cleanser, Cetaphil moisturizer with sunscreen • 60 subjects with facial photodamage enrolled and 58 completed • • • • • Mild/Moderate photodamage: 48 subjects Severe photodamage: 12 subjects Females: 90%, Caucasians: 98% Age range 41 to 65 (Mean age 55) No adverse event related drop-outs • Evaluations at baseline, 1, 3 and 6 months by three techniques: 1. Optical profilometry 2. Visia photographs and independent panel review 3. Investigator’s assessment of photodamage PAGE 26 Copyright ©2008 SkinMedica, Inc. All rights reserved. © 2008 SkinMedica, Inc. All rights reserved. Skin Surface Impression: Periorbital Area Baseline 6 Months Female Age 63 © 2008 SkinMedica, Inc. All rights reserved. Female Age 52 Copyright ©2008 SkinMedica, Inc. All rights reserved. Female Age 62 PAGE 27 9 Significant Reduction of Skin Surface Roughness PAGE 28 Copyright ©2008 SkinMedica, Inc. All rights reserved. © 2008 SkinMedica, Inc. All rights reserved. Independent Panel Review VISIA Images Reviewers: Dr. James Leyden, Dr. Lisa Donofrio and Dr. Timothy Flynn CopyrightCopyright ©2008 SkinMedica, ©2008 All rights Inc. All reserved. rights reserved. 29 PAGE 29 © 2008 SkinMedica, Inc. All rights reserved. 6 Months Baseline © 2008 SkinMedica, Inc. All rights reserved. Copyright ©2008 SkinMedica, Inc. All rights reserved. PAGE 30 10 Investigators assessment: Reduction in Photodamage Copyright ©2008 SkinMedica, Inc. All rights reserved. © 2008 SkinMedica, Inc. All rights reserved. PAGE 31 Double-blind Clinical Efficacy Trial: Summary In clinical studies, TNS Recovery Complex shows: – Statistically significant improvements over vehicle control in: • Fine lines and wrinkles • Facial photodamage scoring • Peri-orbital wrinkling – Statistically significant improvements over baseline in: • Mottled pigmentation and tactile roughness © 2008 SkinMedica, Inc. All rights reserved. Copyright ©2008 SkinMedica, Inc. All rights reserved. PAGE 32 PBGF in Combination Therapy • Growth factors are critical in building extracellular matrix • Other critical agents affecting the reversal of aging are: – Free radical fighting agents – Matrix Metalloproteinases (MMP) Inhibitors – Anti-inflammatory agents • The best anti-aging product is a combination of physiologically balanced growth factors with other critical agents © 2008 SkinMedica, Inc. All rights reserved. PAGE 33 11 Agents Blocking Pathways of Skin Damage AO AO AO RE GF AI AO Antioxidants (including Retinoids) AI Anti-inflammatory RE Retinoids GF Growth Factors improving ECM quality GF PAGE 34 © 2008 SkinMedica, Inc. All rights reserved. TNS Essential Serum™ Chamber 1: APS Corrective Complex™ • • • Peptides: Extracellular matrix building – Dipalmitoyl Hydroxyproline – Palmitoyl Tripeptide-5 – Hydrolyzed Silk Antioxidants: Free-radical scavengers – Ergothioneine (EGT) – Ubiquinone (Coenzyme Q10) – Tocopheryl Acetate – Tetrahexyldecyl Ascorbate – Rubus Fruticosus (Blackberry) Leaf Extract – Camellia Sinensis (Green Tea) Leaf Extract Specialty Ingredients – Alpha-Arbutin-Skin lightener – Hyaluronic Filling Spheres: Immediate filling of fine lines – Aminobutyric Acid (GABA)-Skin tightening © 2008 SkinMedica, Inc. All rights reserved. Chamber 2: TNS Recovery Complex® • • • • 93.6% NouriCel-MD® – 110 Growth Factors and Cytokines – Antioxidants – Matrix proteins Aqueous Gel Formulation – Surfactant free, alcohol free – Oil free, non-comedogenic High Protein Concentration: 50 mg/mL – Ensures stability of growth factors – May improve chance of delivery – Includes penetration enhancers Stabilized Cytokines and Growth Factors – Surfactant-free formula protects growth factors – Proven stability after 24 months storage at room temperature PAGE 35 PBGF Combination Therapy Clinical Study • PBGF mixture with multiple antioxidants, peptides and specialty ingredients serum • Trookman NS, Rizer RL, Ho E, Ford RO, Gotz V. Clinical Efficacy and Tolerance of a Novel Treatment Serum for Photodamaged Facial Skin. Poster presentation Annual AAD Meeting 2009 © 2008 SkinMedica, Inc. All rights reserved. PAGE 36 12 PBGF Combination Therapy : Study Design • 37 subjects enrolled – Twice daily product application in conjunction with a basic skincare regimen including sun protection. • Evaluations at Baseline, 1, 2 and 3 Months: – Investigator Assessments – Elasticity by Cutometer – Digital Photography Trookman et al. Poster presentation at Winter 2009 AAD annual meeting © 2008 SkinMedica, Inc. All rights reserved. PAGE 37 Investigator Assessments: Skin Texture Trookman et al. Poster presentation at Winter 2009 AAD annual meeting © 2008 SkinMedica, Inc. All rights reserved. PAGE 38 Investigator Assessments: Peri-Orbital Wrinkles Trookman et al. Poster presentation at Winter 2009 AAD annual meeting © 2008 SkinMedica, Inc. All rights reserved. PAGE 39 13 Patient 12 Right Forehead Age: 54 After 1 month of PBGF/ antioxidants/peptides Before Treatment Trookman et al. Poster presentation at Winter 2009 AAD annual meeting PAGE 40 © 2008 SkinMedica, Inc. All rights reserved. Patient 28 Right Peri-Orbital Region Age: 47 Before Treatment After 1 month of PBGF/ antioxidants/peptides Trookman et al. Poster presentation at Winter 2009 AAD annual meeting PAGE 41 © 2008 SkinMedica, Inc. All rights reserved. Patient 52 Right Peri-Ocular Area Age: 51 Before Treatment After 3 months of PBGF/ antioxidants/peptides Trookman et al. Poster presentation at Winter 2009 AAD annual meeting © 2008 SkinMedica, Inc. All rights reserved. PAGE 42 14 Patient 4 Frontal View Age: 40 Before Treatment After 1 month of PBGF/ antioxidants/peptides Trookman et al. Poster presentation at Winter 2009 AAD annual meeting PAGE 43 © 2008 SkinMedica, Inc. All rights reserved. Patient 24 Left Peri-Ocular View Age: 49 Before Treatment After 2 months of PBGF/ antioxidants/peptides Trookman et al. Poster presentation at Winter 2009 AAD annual meeting © 2008 SkinMedica, Inc. All rights reserved. PAGE 44 Clinical Trial Evaluating Protection from UV Radiation • Assessment of protection against UVinduced erythema after 10 days of twice daily treatment (N=11) • TNS Essential Serum effect compared to untreated site in same subject • Test skin sites were exposed to a 1 cm diameter spot of UVA/UVB light. – UV radiation was supplied by an artificial source with UV range comparable to that of natural sunlight. Data on file SkinMedica © 2008 SkinMedica, Inc. All rights reserved. PAGE 45 15 Reduction in UVA/UVB Induced Erythema 1 MED 1.5 MED 1 MED 2 MED 1.5 MED Un-treated Data on file SkinMedica MED = Minimal Erythemal Dose 2 MED Treated © 2008 SkinMedica, Inc. All rights reserved. PAGE 46 Reduction in UV Induced Erythema Up to 50% Reduction in UV Induced Erythema in skin treated with TNS Essential Serum over untreated skin PAGE 47 © 2008 SkinMedica, Inc. All rights reserved. PBGF Combination Therapy Summary of Clinical Results • Statistically significant improvements observed in: – Textural Roughness -89% – Fine Wrinkles -30% – Coarse Wrinkles -44% • Statistically significant improvement in skin elasticity • Statistically significant protection (50%) from UVA/UVB exposure © 2008 SkinMedica, Inc. All rights reserved. PAGE 48 16 Conclusion • Human growth factors have a key role in the reversal of aging process • A combination of growth factors affecting multiple pathways of skin repair have been shown to enhance reversal of skin aging • Combination therapy with PBGF, antioxidants, peptides and other ingredients has the potential to impact skin aging and reverse the aging process PAGE 49 © 2008 SkinMedica, Inc. All rights reserved. Discussion © 2008 SkinMedica, Inc. All rights reserved. PAGE 50 17